The presence of hepatitis B varies depending on the different areas of the world; 10 genotypes of hepatitis B virus (HBV) (A to J) have been identified, and they differ from one another in the nucleotide sequence and geographical location. The various genotypes are associated with a different evolution of the disease and with distinct responses to treatment. we assessed the genotype of the HBV virus on 35 specimens with HBV-DNA>1000 IU/mL. The HBV genotype has been determined through sequencing.
Introduction
The presence of hepatitis B varies in the different areas of the World (12) . The hepatitis B virus (HBV) is very widespread also due to its resistance in the environment, with a higher prevalence in China and in Southern Asia and a lower presence in North America and Western Europe: it shows a higher percentage of infection in Central Europe (10, 11) . Ten genotypes of HBV (named with letters from A to J) have been identified (19, 22) . The 10 genotypes differ from one another in the nucleotide sequence and geographical location (15) . Genotype A is widespread in America, North-West Europe and Africa; genotypes B and C prevail in China and Japan, while genotype D is found in Southern Europe, Middle East and India (18) . Genotype E is found in Africa, in the sub-Saharan region, genotype F in Central and South America, genotype G in Eastern and Western Europe and genotype H, a variant of genotype F, from which it has probably broken up within the New World, in Central and South America (2, 12, 18, 21) . Genotype I has recently been reported in Vietnam and Laos and genotype J has been identified in the Ryukyu Islands in Japan, from an old Japanese patient with hepatocellular carcinoma (1, 21, 23, 24) . The various genotypes are associated with a different evolution of the disease and with distinct responses to treatment (18, 22) . The aim of this work is to assess the genotype of the HBV virus in specimens taken from patients with HBV-DNA>1000 IU/mL, at the Immuno-haematology and Blood Transfusion Centre (S.I.T.) of the Santa Maria Hospital in Terni, considering their regions of origin.
Materials and Methods
From January 2010 to March 2014 we assessed the genotype of the HBV virus on 35 specimens belonging to the same number of patients with HBV-DNA>1000 IU/mL (8, 16) . These patients were recruited first to satisfy the rare demands of the clinical, as the HBV genotype is required only in exceptional cases and then based on the availability of the ordered kit during that period.
We considered the samples from Italian and foreign patients with HBV-DNA>1000 IU/mL present in our laboratory, in order to acquire information and expertise in relation to different geographical origin. The assessment of the HBV-DNA was performed on plasma, obtained through the centrifugation (3000 rpm for 20 minutes) of whole blood, taken and transferred into sterile test tubes containing ethylenediaminetetraacetic acid (5) . The quantification of HBV-DNA in specimens was carried out through COBAS AmpliPrep/COBAS TaqMan HBV v2.0 Roche test, which enables the automated extraction and amplification with subsequent detection of the virus nucleic acid (measuring range between 20 and 1.7 E+08 IU/mL) (5) . The HBV genotype was assessed through sequencing. Each specimen was subjected to a manual extraction of the virus (QIAamp DNA Blood Mini Kit, QIAGEN, Venlo, Netherlands) followed by polymerase chain reaction amplification (TRUGENE HBV Genotyping kit; Siemens Medical Solutions Diagnostics, NY, USA), of the central region of the surface antigen gene (s101-s237) and overlapped region encoding the viral reverse transcriptase gene (rt99-rt280) (1, 3) .
The amplicons obtained have been used to prepare the CLIP TM , (trademark of Siemens Healthcare Diagnostics) reaction of sequencing. The DNA specimen to be sequenced has been divided into four CLIP TM sequencing reaction tubes, each one of them contained the DNA polymerase, fluorescent DNA primers to produce bidirectional sequences and all 4 deoxyribonucleotides (dATP, dCTP, dGTP, dTTP). To each one of these reactions we have added just one of the four dideoxy nucleotides (ddATP, ddCTP, ddGTP, ddTTP).
Once concluded the programme in the thermocycler, the DNA was denatured. The sequences obtained have been compared to reference sequences to determine the HBV genotype and the mutations of the analysed specimen (3). Each library contained 7 sequences, one for each HBV genotype (A, B, C, D, E, F and G) (20) . The origin of the studied subjects had been obtained through an epidemiological sheet used for virological researches that we carried out, or through the taxpayer's code number appearing on the requests coming with the individual specimens.
Results
The 35 examined specimens for the genotype of HBV, belonged to as many subjects, with a mean and median age of 42.8 and 40 years respectively: 17 (48.6%) Italians and 18 (51.4%) foreigners. All together there were 19 males: 12 Italians and 7 foreigners. Females were 16: 5 Italians and 11 foreigners (Table 1) . It is evident the prevalence of Italian males and foreign females. The analysed subjects have been divided into four groups, identified by analysing the levels of HBV-DNA found in specimens. The subjects with HBV-DNA≥10 6 IU/mL prevailed: 13 subjects of which 7 Italian males, followed by 11 subjects with HBV-DNA between 1000 IU/mL and 10.000 IU/mL, among which 7 foreign females prevailed (Table 2 ).
In the 35 patients analysed by genotype we found 20 genotypes D (57.2% of total) and 15 non-D genotypes (42.8% of total). Among the non-D genotypes, the genotype with the largest recurrence was genotype A (n=7), followed by genotype C (n=3) and F (n=3) and by genotype B (n=2) ( Table 3) . Genotype B has been found in 2 female patients coming from China and Philippines respectively; genotype C in an Italian patient, in a Bangladeshi patient and in a Thai female patient; genotype F which is usual in Central and South America has been found in 3 Italian patients. Of the 3 Italian patients with genotype F, one reported a long stay in South America where the infection had been contracted; the second patient showed a co-infection with HIV, and reported he regularly visited Colombia. We could not trace the origin and place of infection of the third Italian patient with genotype F and of the two Italian patients with genotype A. Genotype C was found in an Italian patient married to a Thai woman who also suffered from hepatitis B of genotype C.
Discussion and Conclusions
Italy, land of immigration, has become a multi-ethnic country with people coming from high and medium endemic disease areas in terms of HBV (5) . Chronic hepatitis is one of the most widespread infections among immigrants, and it is mainly caused by HBV (13, 14) . According to the data that we collected, the number of foreign subjects (18) is basically equal to the number of the Italian ones (17) that we have analysed (Table 1 ). This shows, despite the limited number of samples (4), the significant presence of foreign people in our area. The exiguity of specimens led us to use in the processing only the frequency calculation. Among women (16) , the majority (11, about 61%) were foreigners. This in accordance with the feminization process of migratory flows occurred in Europe and therefore in Italy, caused an increase in the female population (5) .
We have analysed patients with virological infections, that is to say with HBV-DNA detectable in plasma. The specimens with HBV-DNA≥10 6 IU/mL (15) values prevail and they belong for approximately 54% to Italian males, the biggest group, followed by specimens (11) with HBV-DNA between 10 3 and 10 4 IU/mL where foreign females, as probably predictable, prevail, 7 (about 64%) ( Table 2 ). Of the foreign women analysed, 7 came from Eastern Europe: 4 from Romania, 1 from Poland, 1 from Moldova and 1 from Balkans, Albania (Table 3 ) (9) . The remaining 4 female patients came respectively: 1 from Southern Asia (India), 1 from Eastern Asia (China) and 2 from South-East Asia (Thailand and Philippines). The geographical distribution of HBV genotypes varies from region to region and the different genotypes do not have a regular distribution. The HBV genotype significantly affects the course of the illness: it is a variable that can influence its development both in terms of hepatic disease progression and of effectiveness of therapy (4, 6, 7) . In the Mediterranean areas genotype D prevails (7, 17) .
The analysis of the HBV genotypes distribution allowed us to verify that in the area of the hospital of Terni, genotype D is not the only one existing, but it appears to be present also with other genotypes. Changes in the lifestyle, travels, and international trade can cause the spread among local population of different HBV genotypes. The global migration flow, which is more and more unrestrainable, could lead to a world-wide redistribution and change of genotypes in areas where previously they were not spread: important phenomenon to be monitored. The study of genotypes and of their distribution even in our region appear to be important, because it is correlated with clinical characteristics and with the virological response of HBV infection, in order to find an adequate and targeted therapy (7, 14) . Table 3 . Italian and foreign subjects on whom we performed the research of hepatitis B virus genotype from 2010 to 2014: nationality of origin and found genotypes. Total  M  F  M  F  M  F  M  F  M  F  M  F  M  F  M  F   Italy  2  ---1  -6  5  --3  ---12  5  Romania  2  2  ----1  2  ------3  4  China  ---1  -----------1  Poland  - 
Country Genotype A Genotype B Genotype C Genotype D Genotype E Genotype F Genotype G
1 - - - - - - - - - - - - - 1 Albania - - - - - - 2 1 - - - - - - 2 1 Thailand - - - - - 1 - - - - - - - - - 1 Bangladesh - - - - 1 - - - - - - - - - 1 - India - - - - - - - 1 - - - - - - - 1 Libya - - - - - - 1 - - - - - - - 1 - Philippines - - - 1 - - - - - - - - - - - 1 Moldova - - - - - - - 1 - - - - - - - 1
